Business Context and Reporting Period
This Form 6-K filing by Grande Group Limited covers the month of July 2026, with the report dated July 20, 2026. The Company is a foreign private issuer headquartered in Hong Kong. The filing primarily discloses the entry into a material definite agreement regarding a potential equity financing arrangement.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on the terms of a new share purchase agreement rather than periodic financial performance results.
Material Changes and Agreements
On July 16, 2026, the Company entered into an Ordinary Share Purchase Agreement (SPA) with White Lion Capital, LLC. Key terms include:
- Capacity: The Company may issue up to $40,000,000 in aggregate gross purchase price of newly issued Class A ordinary shares.
- Duration: The agreement is valid for 36 months from the execution date.
- Structure: The Company has the right, but not the obligation, to require the Investor to purchase shares via a purchase notice.
- Pricing Mechanism: Prices are determined based on the average of the four lowest traded prices during a rapid valuation period or 97% of the lowest daily volume-weighted average price (VWAP) during a VWAP purchase valuation period.
- Registration Rights: A Registration Rights Agreement (RRA) was executed simultaneously, requiring the Company to file a registration statement (Form F-1 or F-3) within 30 days of filing its Form 20-F for the fiscal year ended March 31, 2026.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond the standard incorporation by reference of the SPA and RRA. The unusual item noted is the establishment of an "at-the-market" style issuance facility with a specific pricing discount mechanism (97% of VWAP) which could impact existing shareholders through potential dilution.
Investor Verification Checklist
- Verify the exact pricing formula mechanics in the attached Exhibit 10.1 (SPA) to understand potential dilution scenarios.
- Confirm the status of the Form 20-F for the fiscal year ended March 31, 2026, to determine the deadline for the required registration statement under the RRA.
- Review the Company's current cash position to assess the immediate necessity of utilizing this $40 million financing facility.
- Check for any subsequent filings indicating the first purchase notice issued under this agreement.